Menu

Osteoporosis

The extensive range of generic products marketed by Novagen Pharma (Pty) Ltd conform to strict international standards.
Further information is available on request. For full prescribing information refer to the approved Professional Information Leaflet.

Registration Number Trade Name Active Ingredient/Strength Dosage Form Schedule Pack size PIL
45/3.2/0581 Densate® 70 mg Alendronic acid (Sodium Alendronate) 70 mg Tabs S3 4
  • Patient Information Leaflet
    Adobe PDF, 56 KB
    Download

More about: Osteoporosis

Osteoporosis is a progressive bone disease that is characterized by a decrease in bone mass and density which can lead to an increased risk of fracture.

In osteoporosis, the bone mineral density (BMD) is reduced, bone microarchitecture deteriorates and the amount and variety of proteins in bone are altered. The form of osteoporosis most common in women after menopause is referred to as primary type 1 or postmenopausal osteoporosis, which is attributable to the decrease in estrogen production after menopause. Primary type 2 osteoporosis or senile osteoporosis occurs after age 75 and is seen in both females and males at a ratio of 2:1.

Signs and symptoms

Osteoporosis itself has no symptoms; its main consequence is the increased risk of bone fractures. Osteoporotic fractures occur in situations where healthy people would not normally break a bone; they are therefore regarded as fragility fractures. Typical fragility fractures occur in the vertebral column, rib, hip and wrist.1

Reference:

  1. https://en.wikipedia.org/wiki/osteoporosis

E&OE